Your browser doesn't support javascript.
loading
Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromes.
Cogle, Christopher R; Collins, Bradley; Turner, Daniel; Pettiford, Leslie C; Bossé, Raphael; Hawkins, Kimberly E; Beachamp, Zackary; Wise, Elizabeth; Cline, Christina; May, William S; Moreb, Jan S; Hsu, Jack; Hiemenz, John; Brown, Randall; Norkin, Maxim; Wingard, John R; Uckun, Fatih.
Afiliación
  • Cogle CR; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Collins B; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Turner D; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Pettiford LC; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Bossé R; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Hawkins KE; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Beachamp Z; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Wise E; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Cline C; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • May WS; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Moreb JS; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Hsu J; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Hiemenz J; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Brown R; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Norkin M; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Wingard JR; Division of Hematology and Oncology, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Uckun F; Oncotelic Inc, Agoura Hills, CA, USA.
Br J Haematol ; 189(5): e211-e213, 2020 06.
Article en En | MEDLINE | ID: mdl-32236943
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Estilbenos / Síndromes Mielodisplásicos / Profármacos / Leucemia Mieloide Aguda / Terapia Recuperativa / Difosfatos / Antineoplásicos Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Estilbenos / Síndromes Mielodisplásicos / Profármacos / Leucemia Mieloide Aguda / Terapia Recuperativa / Difosfatos / Antineoplásicos Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos